Vanguard Group
BTTX

Vanguard Group’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Vanguard Group’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-198,154
Closed -$38.6K – 4505
2023
Q4 		$38.6K Sell
198,154
-301,743
-60% -$65.6K ﹤0.01% 4389
2023
Q3 		$183K Buy
499,897
+61,418
+14% +$41.4K ﹤0.01% 4266
2023
Q2 		$474K Hold
438,479
– – ﹤0.01% 4134
2023
Q1 		$307K Buy
438,479
+3,700
+0.9% +$4.35K ﹤0.01% 4242
2022
Q4 		$480K Buy
434,779
+135
+0% +$199 ﹤0.01% 4111
2022
Q3 		$765K Buy
434,644
+101,098
+30% +$184K ﹤0.01% 4082
2022
Q2 		$520K Buy
333,546
+49,151
+17% +$82.2K ﹤0.01% 4284
2022
Q1 		$563K Buy
284,395
+80,633
+40% +$279K ﹤0.01% 4375
2021
Q4 		$947K Buy
+203,762
New +$1.67M ﹤0.01% 4282

Other funds holding BTTX

CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.37B AUM 20.71% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
APC
Aspire Private Capital Cornelius, North Carolina $443M AUM 14.48% 1-Year Est. Return